Literature DB >> 17324365

Cerebral sinovenous thrombosis in children.

Jessica Carpenter1, Tammy Tsuchida.   

Abstract

Cerebral sinovenous thrombosis (CSVT) is a rare but increasingly recognized disease process in children. In the pediatric population, the etiologies of CSVT are multiple and the outcomes are variable. The current therapies for CSVT include anticoagulation, thrombolysis, hydration, surgery, and supportive care. Adult studies, pediatric case studies, and expert opinion form the basis for these treatment strategies. International cooperative efforts are currently being undertaken to collect data on pediatric stroke patients, including CSVT. These multicenter collaborations are needed to increase our understanding of the incidence, risk factors, treatment modalities, and outcomes of CSVT in pediatric populations.

Entities:  

Mesh:

Year:  2007        PMID: 17324365     DOI: 10.1007/s11910-007-0009-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  45 in total

1.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis.

Authors:  K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

2.  Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors.

Authors:  S Cakmak; L Derex; M Berruyer; N Nighoghossian; F Philippeau; P Adeleine; M Hermier; J C Froment; P Trouillas
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

3.  Cerebral sinovenous thrombosis in children.

Authors:  G deVeber; M Andrew; C Adams; B Bjornson; F Booth; D J Buckley; C S Camfield; M David; P Humphreys; P Langevin; E A MacDonald; J Gillett; B Meaney; M Shevell; D B Sinclair; J Yager
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

4.  Intracranial MR venography in children: normal anatomy and variations.

Authors:  E Widjaja; P D Griffiths
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  Cerebral venous thrombosis in children.

Authors:  K S Carvalho; J B Bodensteiner; P J Connolly; B P Garg
Journal:  J Child Neurol       Date:  2001-08       Impact factor: 1.987

6.  Heparin treatment in sinus venous thrombosis.

Authors:  K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

7.  Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.

Authors:  Mark E Mullins; P Ellen Grant; Bing Wang; R Gilberto Gonzalez; Pamela W Schaefer
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

Review 8.  Thrombolytics for cerebral sinus thrombosis: a systematic review.

Authors:  Patricia Canhão; Filipa Falcão; José M Ferro
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

9.  Cerebral sinus venous thrombosis in children.

Authors:  C Barnes; F Newall; J Furmedge; M Mackay; P Monagle
Journal:  J Paediatr Child Health       Date:  2004 Jan-Feb       Impact factor: 1.954

10.  [Sickle cell anemia and internal cerebral vein thrombosis].

Authors:  C Di Roio; C Jourdan; A Terrier; F Artru
Journal:  Ann Fr Anesth Reanim       Date:  1997
View more
  2 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Multiple cerebral sinus thromboses complicating meningococcal meningitis: a pediatric case report.

Authors:  Elena Bozzola; Mauro Bozzola; Giovanna Stefania Colafati; Valeria Calcaterra; Annachiara Vittucci; Matteo Luciani; Alberto Villani
Journal:  BMC Pediatr       Date:  2014-06-13       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.